TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

135 hedge funds and large institutions have $512M invested in Theravance Biopharma in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
1.81%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
24
Increased
54
Reduced
32
Closed
20
Calls
$3K
Puts
$286K
Net Calls
-$283K
Net Calls Change
-$273K

Top Buyers

1
BlackRock
BlackRock
New York
$45.7M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$5.55M
3
JFG
Jefferies Financial Group
New York
$3.05M
4
NM
Newtyn Management
New York
$54.6M
5
Morgan Stanley
Morgan Stanley
New York
$6.07M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
$4.96M
2
NL
Nuveen LLC
North Carolina
$1.33M
3
Millennium Management
Millennium Management
New York
$483K
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
$0
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
$223K
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$2.26M +$1.01M +91,341 +80%
Goldman Sachs
27
Goldman Sachs
New York
$2.2M -$123K -11,150 -5%
Tudor Investment Corp
28
Tudor Investment Corp
Connecticut
$2.17M -$110 -10 -0%
Wellington Management Group
29
Wellington Management Group
Massachusetts
$1.85M +$132K +12,000 +8%
TI
30
Trexquant Investment
Connecticut
$1.73M -$93.7K -8,494 -5%
GCP
31
GSA Capital Partners
United Kingdom
$1.52M -$490K -44,399 -24%
CSS
32
Cubist Systematic Strategies
Connecticut
$1.5M +$978K +88,684 +189%
Barclays
33
Barclays
United Kingdom
$1.45M +$879K +79,769 +153%
CLGM
34
Capitolis Liquid Global Markets
New York
$1.4M +$1.4M +127,200 New
NL
35
Nuveen LLC
North Carolina
$1.33M -$2.81M -254,364 -68%
PP
36
PDT Partners
New York
$1.33M +$350K +31,750 +36%
JPMorgan Chase & Co
37
JPMorgan Chase & Co
New York
$1.32M -$411K -37,304 -24%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.22M -$76.7K -6,953 -6%
Marshall Wace
39
Marshall Wace
United Kingdom
$1.11M +$947K +85,867 +576%
American Century Companies
40
American Century Companies
Missouri
$1.01M +$63.9K +5,794 +7%
JF
41
Jump Financial
Illinois
$872K +$872K +79,074 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$773K -$36.4K -3,300 -4%
MAM
43
Martingale Asset Management
Massachusetts
$759K +$82.8K +7,511 +12%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$689K +$17.5K +1,588 +3%
HF
45
HRT Financial
New York
$648K +$455K +41,340 +236%
NSEDCP
46
NJ State Employees Deferred Compensation Plan
New Jersey
$641K – – –
HSBC Holdings
47
HSBC Holdings
United Kingdom
$638K +$638K +57,214 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$632K -$54.6K -4,946 -8%
Connor, Clark & Lunn Investment Management (CC&L)
49
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$624K +$624K +56,613 New
MCP
50
Militia Capital Partners
Nevada
$598K +$598K +54,200 New
1
2
3 4 5